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Tuberculosis (TB) is still a widespread world infectious disease. Mycobacterium tuberculosis kills more 
people than any other single pathogen, with an estimated one-third of the world's population being 
infected. According to the World Health Organization (WHO), two billion people are infected with the 
causative bacillus of Mycobacterium tuberculosis. Tuberculosis is rather prevalent in the country of 
Georgia today. Frequency distribution of ABO, Rh-Hr, MN, Kell blood group system antigens were 
studied in 277 TB patients (151-drug-sensitive and 126 drug-resistant) of pulmonary tuberculosis to 
know whether there was any association between them, and also between drug resistance and 
sensitiveness. They were compared with 485 healthy subjects. Tests were carried out by standard test-
tube technique and plate reaction for the following antigens: A, B; C, c, D, E, e; K and k, M and N. The 
research materials were collected from Tuberculosis and Lung Diseases National Centre of Georgia and 
Ptisio-pulmonogical Hospital of Adjara Region (Georgia). Present serological study has shown high 
frequency distribution of 0 and B phenotypes and r allele from ABO system, D antigen from Rh-Hr 
system and M antigen from MN blood group in TB patients then healthy subjects. This might explain the 
sensitivity of these antigens with pulmonary tuberculosis in Georgia. No significant difference between 
drug resistant and drug sensitive TB was found, thus the research in this direction has no importance. 
No association existed even when divided by age group in incidence of pulmonary tuberculosis. 
 






Tuberculosis (TB) is still a widespread world infectious 
disease. Mycobacterium tuberculosis kills more people 
than any other single pathogen (Leandro, 2009). Accor-
ding to WHO, there were an estimated 8.8 million incident 
cases (range, 8.5 million to 9.2 million), 12.0 million pre-
valent (range, 11.0 million to 14.0 million) and 1.1 million 
deaths (range, 0.9 million to 1.2 million) occurred among 
HIV-negative cases of TB globally in 2010 (WHO, 2010). 
It is estimated that one-third of the World's population is 
infected with M. tuberculosis, but that only one in 10 
(10%) of those infected ever develop clinical disease. 
The global burden of tuberculosis remains enormous, 
mainly because of poor control in Southeast Asia, sub- 
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and because of high rates of M. tuberculosis and HIV 
coinfection in some African countries (Dye, 1999). Tuber-
culosis has emerged as an enormous public health pro-
blem in former Soviet republics due to economic decline 
and the general failure of tuberculosis control and other 
health services following the breakup of the Soviet Union 
(Weinstock, 2001; Zalesky, 1999). The country of Geor-
gia, an independent nation that was previously part of the 
former union has one of the highest rates of tuberculosis 
among former Soviet republics. Drug resistant Tb, espe-
cially MDR-TB (multidrug resistant) Tb, is associated with 
significantly higher morbidity and mortality than drug 
susceptible disease and emerged serious public health 
problem in the country of Georgia (Mdivani, 2008; 
Espinal, 2000). There were estimated 9.5 (8.2 to 11) % 
new and 31(27 to 35) % retreatment cases of MDR-TB in 
Georgia in 2010 (WHO, 2010). 




It is known that genetic and non-genetic factors of both 
- the bacterium and the host have impact on the immune 
response to M. tuberculosis (Saha, 1968). Twins studies 
and variations in the outcome of tuberculosis infection 
after exposure to similar environmental risk suggest ge-
netic heterogeneity among individuals in the susceptibility 
to disease (Leandro, 2009; Harward and Hauge, 1965). 
Nowadays, the host genetic makeup in relation to sus-
ceptibility or resistance to infections has gained impor-
tance. There are several demonstrations that suscepti-
bility to tuberculosis is linked to host genetic factors; 
inherited predisposition plays an important role in deve-
lopment of tuberculosis (Kramnik , 2000; Gra, 2010; Abel, 
2000). Among the various factors that contribute to a 
person’s genetic individuality are antigens that are the 
major alloantigen in humans, attached to surface of red 
blood cells and naturally occurring antibodies that circu-
late in the serum. The various combinations of their 
antigens and antibodies determine various blood groups 
(Saha, 1968; Naumov, 1993).   
Earlier studies have shown association between some 
genetic markers such as ABO blood group antigens, HLA 
antigens, serum proteins with tuberculosis (Selvaraj, 
2004; Seth, 2003).  It was also reported earlier that there 
was a change in the pattern of the immunological res-
ponse to Mycobacterium tuberculosis in individuals with 
different blood groups (Lewis, 1961; Naumov, 1993; 
Garraty, 2000). Studies on association of blood groups 
with pulmonary tuberculosis date back to 1926 when 
Halber and Hirzfels first reported their negative findings. 
Since then conflicting reports have been published by 
different authors from different countries (Thamaria, 
1972; Rao, 1994). Information about various red cell mar-
kers association with the disease, especially separately 
drug-resistant and other features of pulmonary tuberculo-
sis is unknown in Georgian population. 
Therefore, this pilot study was planned to fill this void 
by providing phenotype and allele frequency distributions 
of as many as 10 different red cell genetic markers of 
different blood group systems in patients with drug resis-
tant and drug sensitive forms of pulmonary tuberculosis 
in Georgia.  
 
 
MATERIALS AND METHODS 
 
The research materials (blood) were collected from Tuberculosis 
and Lung Diseases National Centre of Georgia (The Caucasus) 
and Ptisio-pulmonogical Hospital of Adjara Region (Georgia). 
Investigations were done on total 277 patients with a clinical and 
radiological evidence of pulmonary tuberculosis during 1998 to 
2011. Blood samples were collected from the patients with drug 
sensitive (151 subjects) and drug-resistant (126 subjects) TB. All 
the subjects were between 17 and 75 years of age. As a control 
series, healthy individuals of Adjara Region were investigated. 
From each subject about 1 ml blood was taken and collected in a 
centrifuge vial containing ethylenediaminetetraacetic acid (EDTA) 
as an anticoagulant. Blood samples were immediately transported 
to the laboratory at the Department of Biology, Shota Rustaveli 





The study was approved by the institutional Ethical Committee of 
Tuberculosis and Lung Diseases National Centre of Georgia. 
Blood groups were tested by standard Immuno-serological 
methods with monoclonal antibodies and for calculating allele 
frequencies the data were processed by Statistical methods.  
Using immune-serologic methods, we investigated 10 erythrocyte 
group antigens (two of the ABO system: A, B; five of the RH 
system: C, c, D, E, e, Kell system: K and two of the MN system: M 
and N antigens). 
In the course of the work, the following specific test systems were 
used: anti -B, -A, -D, -C, - c, -E, -e, -K, -M, -N (Gemostandart 
Limited., Moscow), standard 0(I), A(II), B(III) group erythrocytes and 
standard 0(I), A(II), B(III), AB (IV) serums (the titer of the used 
reagents was not lower than 1:32). The obtained results were 
statistically processed. The ABO system genes alleles’ frequency 
was computed by the formula proposed by F. Bernstein and used in 
investigation of three-allele genetic systems. The frequency of the 
0, A and B genes in the given case will be indicated by the letters r, 
p and q:  
 
r = O ; 
p = 1- √A +O; 
q = 1- √B +O. 
 
Where 0, A and B – 0(I), A(II) and B(III) are the ratio of the group 
carrier people in relation to the total number of the subjects of the 
study. The frequency of the Rh-system genes and haploid types 
was computed by using the following formulas: 
 
1. D = 1 -√ dd ; 
2. C = 1 - √cc ; 
3. E = 1 -√ ee ; 
4. c = 1 - √CC ; 
5. e = 1 -√ EE . 
 
Where, D, C, E, c, e are the number of the gene-carrying persons in 
correlation with the number of the study subjects, dd, cc, ee, CC 
and EE are the corresponding phenotype  frequency. The Rh-
haplotypes frequency is computed by the formula proposed by A. E. 
Mourant:  
 
1.  cde = √ccddee ; 
 
2.       
              
3.   
              
4.                         
 
5. cDE=√ccDEE+cdE
2      
-  cdE; 
 
6. CDe = √CCDee +Cde
2     




Where, ccddee, Ccddee, ccddEe, ccDee, CCDee and ccDEE are 
the corresponding phenotypes’ frequency. The RhD and Kell-
system alleles’ concentration was computed under the following  
formula:  









Number of observed individuals 
Drug-sensitive Drug- resistant Donor 
ABO O 53.6 ± 4.0 48.4 ± 4.4 47.6 ± 5.3 
 A 27.8 ± 3.6 35.7 ± 4.2 36.4 ± 5.1 
 B 14.5 ± 2.8 9.5 ± 2.6 11.4 ± 3.3 
 AB 3.9 ± 1.5 5.5 ± 2.0 4.2 ± 2.0 
     
Rh-Hr (D) Rh+ 85 ± 2.8 81 ± 3.5 78 ± 4.1 
 RH- 14 ± 2.8 19 ± 3.4 22 ± 4.1 
     
MN M 71.5 ± 3.6 59.5 ± 4.3 50.2± 
 MN 15.2 ± 2.9 30.9 ± 4.1 29.4± 
 N 13.2 ± 2.7 9.5 ± 2.6 20.2± 
     
Kell K+ 5.9 ± 1.9 7.1 ± 2.2 4.2 ± 2.3 
 K- 93.3 ± 2.0 92.8 ± 2.3 95.8 ± 3.2 
 









number of observed individuals 
Drug-sensitive Drug- resistant Donor 
ABO r 0.72 0.69 0.68 
 p 0.11 0.09 0.09 
 q 0.23 0.25 0.23 
     
MN p (N) 0.2 0.25 0.35 
 q (M) 0.79 0.75 0.65 
     
Kell p(K) 0.07 0.06 0.02 
 q(k) 0.93 0.94 0.97 
 






P = 1– q. 
 
Where, naa is the recessive homozygotes (dd and kk) by the 
indicated loci, N is the total number of the studied subjects. In order 
to establish the concentration of the MN system alleles, the 






Where, nA is the number of the M-phenotype carriers, nAB - of the 
MN phenotype, and nB is the number of the N- phenotype carriers. 
The errors in the frequency of genes were computed by the 
formula: M =_ P P) / n (28),  here P is the frequency of 
antigens in %, n is the number of the study subject. 
 
 
RESULTS AND DISCUSSION 
 
Investigations were done on different blood group anti-
gens, alleles and haplotypes to ascertain their distribution 
and correlation with drug-sensitive and drug resistant 
pulmonary tuberculosis (PTB) patients. Phenotypic distri-
butions of blood groups in tuberculosis patients along 
with healthy subjects are shown in Table 1. Allele and 
haplotype frequencies of the studied marker systems are 
listed in Tables 2 and 3.  




Table 3.  Distribution of Rh-Hr  group system antigens and Rh haplotypes in tuberculosis 






Number of observed individuals 
Drug-sensitive Drug- resistant Donor 
Rh-Hr 
D 0.63 0.57 0.54 
d 0.6 0.58 0.43 
C 0.44 0.36 0.28 
c 0.78 0.7 0.74 
E 0.26 0.11 0.11 
e 0.83 0.86 0.87 
    
cde 0.37 0.41 0.436 
Cde 0.014 0.004 0.006 
cdE 0.008 - - 
cDe 0.102 0.15 0.148 
cDE 0.15 0.08 0.126 
CDe 0.033 0.28 0.192 
CDE 0.016 0.003 0.004 
 




Investigations on ABO system phenotype groups have 
revealed high spread frequency of O(I) (53.6 ± 4.0%) and 
B(III) (14.5 ± 2.8%) phenotype in patients with drug 
sensitive TB, but not in drug resistant patients. Here, it 
was observed that they had lower concentration than 
control subjects, explaining the unequal number of Tb 
research groups. A(II) phenotype is significantly low in 
drug-sensitive tuberculosis (27.8 ± 3.6%) compared with 
control series (36.4 ± 5.1%). Differentiated search accor-
ding to drug sensitiveness has not shown any significant 
findings. Our finding suggests that high frequency of O(I) 
and B(III) phenotype points to the association with tuber-
culosis and may play a role in susceptibility development 
of active tuberculosis after mycobacterial infection. Due 
to the limited number of individuals with AB(IV) pheno-
type, it is difficult to discuss any association with them.   
There was analysis of the frequency distribution of r(O), 
p( A), q(B) alleles of ABO system. Similar patterns were 
observed between total TB patients and control subjects. 
No significant association was revealed. 
The study of Rh-Hr phenotype system revealed that 
pulmonary tuberculosis correlates with Rh+ phenotype; 
higher concentration revealed  D antigen (85.4 ± 2.8%) in 
both drug-sensitive and drug-resistant (80.9 ± 35%) pati-
ents, compared with control subjects (78 ± 4.1%). 
Red cell single antigen of Rh-Hr blood group is un-
equally distributed in all of the three research groups. It 9 
drug-resistant patients. It is noticeable that concentration 
of e antigen is higher in control subjects. 
Among the Rh haplotype, cde is a generally wide 
spread haplotype but the concentration is lower in disea-
sed people than the control series. It should be men-
tioned that CDe haplotype is significantly high (0.28) in 
drug resistant patients. The fixed least amount of cde, 
CDe and CDE haplotypes is among Rh blood group 
system haplotypes. 
Regarding the MN system, significant association was 
revealed between MN system groups and both pattern of 
TB patients. Research has shown correlation of MM (71.5 
± 3.6%) phenotype with drug sensitive tuberculosis and 
the majority of MN phenotype in drug resistant patients 
(30.9 ± 4.1%). This suggests that there is significant 
association between M antigen and pulmonary tuberculo-
sis.   
Spreading of Kell blood group phenotipes and alleles 
was almost equally distributed in research subjects and 
healthy individuals. It may point out little association bet-
ween  K+ phenotype with drug resistant TB; and that P 






Present serological study has shown high frequency 
distribution of 0 and B phenotypes and r allele of ABO 
system, D antigen of Resus system and M antigens of 
MN blood group in TB patients. This be the reason for the 
sensitivity of mentioned phenotype groups and antigens 
with pulmonary tuberculosis in Georgia. There was no 
significant difference between drug resistant and drug 






Abel L, Casanova JL (2000). Genetic Predisposition to Clinical 
Tuberculosis: Bridging the Gap between Simple and Complex 





Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC (1999). For the 
WHO Global Surveillance and Monitoring Project. Global burden of 
tuberculosis: estimated incidence, prevalence, and mortality by 
country. JAMA 282:677-686. 
Espinal MA, Kim SJ, Suarez PG, Kam KM, Khomenko AG, Migliori GB, 
et al ( 2000). Standard short-course chemotherapy for drug-resistant 
tuberculosis: treatment outcomes in 6 countries. JAMA; 
283(19):2537-45.  
Garratty G (2000). The blood groups and disease: a historical 
perspective. Transfus Med Rev. 14(4):291-301. 
Gra OA, Kozhekbaeva ZhM, Skotnikova  OI, Litvinov  VI, Nasedkina TV 
(2010). Analysis of Genetic Predisposition to Pulmonary Tuberculosis 
in Native Russians. ISSN 1022_7954, Rus. J. Genet. 46(2):230-238. 
Harvald H, Hauge M (1965). Hereditary factors elucidated by twin 
studies. In: Genetics and the epidemiology of chronic diseases. 
Washington: S Department of Health, Education and Welfare, US 
Public Health Service, Division of Chronic Diseases:  pp. 61-76.  
Hoal EG (2002). Human genetic susceptibility to tuberculosis and other 
mycobacterial diseases. IUBMB Life; 53(4-5):225-229. 
Kramnik I, Dietrich W F, Demant P, Bloom B R (2000). Genetic control 
of resistance to experimental infection with virulent Mycobacterium 
tuberculosis. Proceed. Nat. Acad. Sci. USA. 97(15): 8560-8565. 
Leandro AC, Rocha MA, Cardoso CS, Bonecini-Almeida MG (2009). 
Genetic polymorphisms in vitamin D receptor, vitamin D-binding 
protein, Toll-like receptor 2, nitric oxide synthase 2, and interferon-
gamma genes and its association with susceptibility to tuberculosis. 
Braz. J. Med. Biol. Res. 42(4):312-22. 
Lewis JG (1961). The ABO and rhesus blood groups in patients with 
















































Naumov VN, Shaĭkhaev AI, Pospelov LE, Testov VV (1993). 
Immunogenetic factors in pulmonary tuberculosis surgery.  Probl. 
Tub. (4):17-9Rao S Rao S (1994). Pulmonary tuberculosis and ABO 
blood groups: an association? Department of Tuberculosis and Chest 
Diseases, Kasturba Hospital, Manipal-576 199 Lung India. 12(1):35-
36. 
Saha N (1985). Blood groups and diseases. Singapore Med. J. 26 
(6).(The year 1985 was not cited in the body of the work. Please cite). 
Saha N. and Banergee  B (1968). Incidence of ABO and RH Blood 
Groups in Pulmonary Tuberculosis in Different Ethnic Groups. J. 
med. Genet. 5: 306. 
Selvaraj P (2004). Host genetics and tuberculosis susceptibility. Curr. 
Sci. 86 (1). 
Seth N and Chahal SMS (2003). A Study of Red Cell Genetic Markers 
in Pulmonary Tuberculosis. Anthropologist. 5(1):53-56.  
Weinstock DM, Hahn O, Wittkamp M, Sepkowitz KA, Khechinashvili G, 
Blumberg HM (2001) Risk for tuberculosis infection among internally 
displaced persons in the Republic of Georgia. Int. J. Tuberc. Lung 
Dis. 5(2):164-169. 
World Health Organization (2010). Global tuberculosis control: WHO 
report 2010 (Geneva: WHO, 2010).  
Zalesky R, Abdullajev F, Khechinashvili G, Safarian M, Madaras T, 
Grzemska M, Englund E, Dittmann S, Raviglione M (1999). 
Tuberculosis control in the Caucasus: successes and constraints in 
DOTS implementation. Int. J. Tuberc Lung Dis. 3(5):394-401. 
 
 
 
